Medicilon offers a full range of Bioanalytical Services supporting various aspects of the drug discovery and development continuum, including discovery biology, in vitro ADME, preclinical PK/PD, GLP-compliant toxicology, as well as bioequivalence studies and clinical trials.
Led by Dr. Baomin Xin, a well-established expert from Bristol-Myers Squibb, our experienced team is dedicated to bioanalytical sciences and has up-to-date knowledge of compliance requirements. We utilize the latest platforms and technologies from Sciex, Waters, Shimadzu, Hamilton Star, Gyros, BioPlex, MSD, and Thermo Watson, to generate high-quality data and help you to turn your molecules to medicines quickly and cost-effectively.